Oral Submucous Fibrosis (OSMF) is a chronic progressive debilitating high risk precancerous condition resulting in increased juxtaepithelial fibrosis of oral mucosa, the oropharynx, and rarely, the larynx leading to burning and stiffness of oral mucosa and often leads to ongoing reduced mouth opening. A number of treatment modalities for OSMF have been proposed with little reliable evidence for the effectiveness of each/any of these in the management of this condition. These treatment protocols can dilute the signs and symptoms of OSMF, but no single treatment modality can be identified which can provide a complete cure of this disease. The present review highlights the importance of habit control, physical therapy, intraoral appliance, medicinal and surgical interventions in the management of OSMF and identify gaps in our knowledge to encourage further research to help develop targeted therapies.
Key words: Oral submucous fibrosis, corticosteroids, management
Received: 15 May, 2019 Revised: 02 June 2019 Accepted: 05 June 2019
Corresponding author: Dr. Aayushi Arora, Intern, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar
This article may be cited as: Arora A. Treatment Modalities in Oral Submucous Fibrosis: A Review. J Adv Med Dent Scie Res 2019;7(9): 11-15.